Literature DB >> 27190312

Sublytic C5b-9 triggers glomerular mesangial cell apoptosis in rat Thy-1 nephritis via Gadd45 activation mediated by Egr-1 and p300-dependent ATF3 acetylation.

Fengxia He1, Mengya Zhou1, Tianyi Yu1, Dan Zhao1, Jing Zhang1, Wen Qiu1, Yanlai Lu1, Yu Liu1, Lulu Wang1, Yingwei Wang2.   

Abstract

The apoptosis of glomerular mesangial cells (GMCs) is considered to be an important contributor to the initiation and development of rat Thy-1 nephritis (Thy-1N) and is accompanied by sublytic C5b-9 deposition. However, the mechanism by which sublytic C5b-9 triggers GMC apoptosis has not been elucidated. In this study, functional and histological examinations were performed on GMCs treated with sublytic C5b-9 (in vitro) and renal tissues of Thy-1N rats (in vivo). The in vitro studies found that sublytic C5b-9 could trigger GMC apoptosis through upregulating Egr-1, ATF3, and Gadd45 expression. Egr-1-mediated post-transcriptional modulation of ATF3, Egr-1/ATF3-enhanced Gadd45 promoter activity, and p300-mediated ATF3 acetylation were all involved in GMC apoptosis. More importantly, the effective binding elements for Egr-1 and ATF3 to Gadd45β/γ promoters and the ATF3 acetylation site were identified. In vivo, silencing renal p300, Egr-1, ATF3, and Gadd45β/γ significantly decreased GMC apoptosis, secondary GMC proliferation, and urinary protein secretion in Thy-1N rats. Together, these findings implicate that sublytic C5b-9-induced activation of Egr-1/p300-ATF3/Gadd45 axis plays a critical role in GMC apoptosis in Thy-1N rats.
© The Author (2016). Published by Oxford University Press on behalf of Journal of Molecular Cell Biology, IBCB, SIBS, CAS. All rights reserved.

Entities:  

Keywords:  Thy-1 nephritis; acetylation; apoptosis; glomerular mesangial cells; sublytic C5b-9; transcription factor

Mesh:

Substances:

Year:  2016        PMID: 27190312     DOI: 10.1093/jmcb/mjw021

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN: 1759-4685            Impact factor:   6.216


  7 in total

1.  Podocyte histone deacetylase activity regulates murine and human glomerular diseases.

Authors:  Kazunori Inoue; Geliang Gan; Maria Ciarleglio; Yan Zhang; Xuefei Tian; Christopher E Pedigo; Corey Cavanaugh; Janet Tate; Ying Wang; Elizabeth Cross; Marwin Groener; Nathan Chai; Zhen Wang; Amy Justice; Zhenhai Zhang; Chirag R Parikh; Francis P Wilson; Shuta Ishibe
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

2.  Sublytic C5b-9 induces glomerular mesangial cell proliferation via ERK1/2-dependent SOX9 phosphorylation and acetylation by enhancing Cyclin D1 in rat Thy-1 nephritis.

Authors:  Mengxiao Xie; Zhijiao Wu; Shuai Ying; Longfei Liu; Chenhui Zhao; Chunlei Yao; Zhiwei Zhang; Can Luo; Wenbo Wang; Dan Zhao; Jing Zhang; Wen Qiu; Yingwei Wang
Journal:  Exp Mol Med       Date:  2021-04-02       Impact factor: 8.718

3.  Egr-1 regulates RTA transcription through a cooperative involvement of transcriptional regulators.

Authors:  Roni Sarkar; Subhash C Verma
Journal:  Oncotarget       Date:  2017-09-05

4.  Identifying of miRNA-mRNA Regulatory Networks Associated with Acute Kidney Injury by Weighted Gene Co-Expression Network Analysis.

Authors:  Jie Xu; Yunfei Xu
Journal:  Int J Gen Med       Date:  2022-02-19

5.  KLF6 Acetylation Promotes Sublytic C5b-9-Induced Production of MCP-1 and RANTES in Experimental Mesangial Proliferative Glomerulonephritis.

Authors:  Tianyi Yu; Yajuan Gong; Yu Liu; Lu Xia; Chenhui Zhao; Longfei Liu; Mengxiao Xie; Zhijiao Wu; Dan Zhao; Wen Qiu; Yingwei Wang; Jing Zhang; Mingde Ji
Journal:  Int J Biol Sci       Date:  2020-06-20       Impact factor: 6.580

6.  C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.

Authors:  Chenhui Zhao; Yongting Li; Wen Qiu; Fengxia He; Weiming Zhang; Dan Zhao; Zhiwei Zhang; Erbao Zhang; Pei Ma; Yiqian Liu; Ling Ma; Fengming Yang; Yingwei Wang; Yongqian Shu
Journal:  Oncogene       Date:  2018-05-18       Impact factor: 9.867

Review 7.  Master Regulator Activating Transcription Factor 3 (ATF3) in Metabolic Homeostasis and Cancer.

Authors:  Hui-Chen Ku; Ching-Feng Cheng
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-14       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.